Telesis Bio, Inc. (TBIO)
Total Valuation
Telesis Bio has a market cap or net worth of $13.19 million. The enterprise value is $21.48 million.
Market Cap | 13.19M |
Enterprise Value | 21.48M |
Important Dates
The last earnings date was Thursday, March 28, 2024, after market close.
Earnings Date | Mar 28, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Telesis Bio has 29.98 million shares outstanding. The number of shares has increased by 1.45% in one year.
Shares Outstanding | 29.98M |
Shares Change (YoY) | +1.45% |
Shares Change (QoQ) | +0.58% |
Owned by Insiders (%) | 37.70% |
Owned by Institutions (%) | 38.38% |
Float | 9.14M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.44 |
Forward PS | 0.40 |
PB Ratio | 0.74 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.72 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.07, with a Debt / Equity ratio of 2.81.
Current Ratio | 2.07 |
Quick Ratio | 1.85 |
Debt / Equity | 2.81 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -23.96 |
Financial Efficiency
Return on equity (ROE) is -120.70% and return on invested capital (ROIC) is -54.67%.
Return on Equity (ROE) | -120.70% |
Return on Assets (ROA) | -39.90% |
Return on Capital (ROIC) | -54.67% |
Revenue Per Employee | $134,534 |
Profits Per Employee | -$174,395 |
Employee Count | 223 |
Asset Turnover | 0.31 |
Inventory Turnover | 3.51 |
Taxes
In the past 12 months, Telesis Bio has paid $27,000 in taxes.
Income Tax | 27,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.06% in the last 52 weeks. The beta is 1.98, so Telesis Bio's price volatility has been higher than the market average.
Beta (1Y) | 1.98 |
52-Week Price Change | -84.06% |
50-Day Moving Average | 0.43 |
200-Day Moving Average | 0.86 |
Relative Strength Index (RSI) | 44.97 |
Average Volume (30 Days) | 788,004 |
Short Selling Information
The latest short interest is 226,264, so 0.75% of the outstanding shares have been sold short.
Short Interest | 226,264 |
Short Previous Month | 341,819 |
Short % of Shares Out | 0.75% |
Short % of Float | 2.48% |
Short Ratio (days to cover) | 0.11 |
Income Statement
In the last 12 months, Telesis Bio had revenue of $30.00 million and -$38.89 million in losses. Loss per share was -$1.30.
Revenue | 30.00M |
Gross Profit | 18.65M |
Operating Income | -37.00M |
Pretax Income | -38.14M |
Net Income | -38.89M |
EBITDA | -32.79M |
EBIT | -36.61M |
Loss Per Share | -$1.30 |
Balance Sheet
The company has $41.63 million in cash and $49.92 million in debt, giving a net cash position of -$8.29 million or -$0.28 per share.
Cash & Cash Equivalents | 41.63M |
Total Debt | 49.92M |
Net Cash | -8.29M |
Net Cash Per Share | -$0.28 |
Equity / Book Value | 17.77M |
Book Value Per Share | 0.59 |
Working Capital | 27.29M |
Cash Flow
In the last 12 months, operating cash flow was -$32.99 million and capital expenditures -$2.48 million, giving a free cash flow of -$35.47 million.
Operating Cash Flow | -32.99M |
Capital Expenditures | -2.48M |
Free Cash Flow | -35.47M |
FCF Per Share | -$1.18 |
Margins
Gross margin is 62.15%, with operating and profit margins of -123.34% and -129.63%.
Gross Margin | 62.15% |
Operating Margin | -123.34% |
Pretax Margin | -127.14% |
Profit Margin | -129.63% |
EBITDA Margin | -109.29% |
EBIT Margin | -122.04% |
FCF Margin | -118.23% |
Dividends & Yields
Telesis Bio does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.45% |
Shareholder Yield | -1.45% |
Earnings Yield | -294.78% |
FCF Yield | -268.85% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | Hold |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Telesis Bio has an Altman Z-Score of -2.33 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -2.33 |
Piotroski F-Score | 3 |